Giorgio Berton
University of Milan
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Giorgio Berton.
Nature Medicine | 2015
Elena Zenaro; Enrica Caterina Pietronigro; Vittorina Della Bianca; Gennj Piacentino; Laura Marongiu; Simona Luciana Budui; Ermanna Turano; Barbara Rossi; Stefano Angiari; Silvia Dusi; Alessio Montresor; Tommaso Carlucci; Sara Nanì; Gabriele Tosadori; Lucia Calciano; Daniele Catalucci; Giorgio Berton; Bruno Bonetti; Gabriela Constantin
Inflammation is a pathological hallmark of Alzheimers disease, and innate immune cells have been shown to contribute to disease pathogenesis. In two transgenic models of Alzheimers disease (5xFAD and 3xTg-AD mice), neutrophils extravasated and were present in areas with amyloid-β (Aβ) deposits, where they released neutrophil extracellular traps (NETs) and IL-17. Aβ42 peptide triggered the LFA-1 integrin high-affinity state and rapid neutrophil adhesion to integrin ligands. In vivo, LFA-1 integrin controlled neutrophil extravasation into the CNS and intraparenchymal motility. In transgenic Alzheimers disease models, neutrophil depletion or inhibition of neutrophil trafficking via LFA-1 blockade reduced Alzheimers disease–like neuropathology and improved memory in mice already showing cognitive dysfunction. Temporary depletion of neutrophils for 1 month at early stages of disease led to sustained improvements in memory. Transgenic Alzheimers disease model mice lacking LFA-1 were protected from cognitive decline and had reduced gliosis. In humans with Alzheimers disease, neutrophils adhered to and spread inside brain venules and were present in the parenchyma, along with NETs. Our results demonstrate that neutrophils contribute to Alzheimers disease pathogenesis and cognitive impairment and suggest that the inhibition of neutrophil trafficking may be beneficial in Alzheimers disease.
American Journal of Respiratory Cell and Molecular Biology | 2011
Mariacristina Dechecchi; Elena Nicolis; Paola Mazzi; Cioffi F; Bezzerri; Lampronti I; Huang S; Wiszniewski L; Roberto Gambari; Scupoli Mt; Giorgio Berton; Giulio Cabrini
The investigation of novel targets for the treatment of cystic fibrosis (CF) lung inflammation is a major priority, considering that no effective therapy is available for this purpose. Consistent with the evidence that the sphingolipid (SL) ceramide regulates airway inflammation and infection in mice and patients with CF, SLs were identified as targets for treating pulmonary disorders, including CF. Because miglustat, an inhibitor of the synthesis of glycosphingolipids, reduces the Pseudomonas aeruginosa-dependent transcription of the IL-8 gene in bronchial cells, we examined the effects of miglustat and amitriptyline, another drug affecting ceramide metabolism, on the expression of 92 genes implicated in host immune defense. Infection with the P. aeruginosa strain PAO1 up-modulated the expression of 14 (27%) genes in IB3-1 cells and 15 (29%) genes in CF primary respiratory epithelia grown at an air-liquid interface, including chemokines (IL-8, growth-regulated Gro-α/β/γ proteins, and granulocyte chemotactic peptide-2 [GCP-2]), proinflammatory cytokines (IL-1α/β, IL-6, and TNF-α), and the intercellular adhesion molecule-1, nuclear factor kB1, toll like receptor 2, and human defensin B4 genes, confirming that bronchial epithelium is an important source of inflammatory mediators. Both miglustat and amitriptyline reduced the immune response, an effect that paralleled a decrease in the P. aeruginosa-induced accumulation of ceramide. Miglustat (100 mg/kg), given to C57BL/6 mice once daily for a period of 3 consecutive days before lipopolysaccharide (LPS) challenge, strongly reduced the number of neutrophils recruited in the airways and the expression of the keratinocyte-derived chemokine in lung extracts. Collectively, these results indicate that targeting the metabolism of SLs can down-modulate the recruitment of neutrophils into the lung.
FEBS Letters | 1994
Gabriela Constantin; Carlo Laudanna; Pierluigi Baron; Giorgio Berton
We investigated whether sulfatides are able to trigger transmembrane signals and activation of selective cell functions in human monocytes. Sulfatides stimulated an increase in cytosolic free‐calcium in monocytes, and this depended on the release of calcium from intracellular stores. Non‐sulfated galactocerebrosides had no effect on monocyte cytosolic free calcium. Sulfatides enhanced expression of tumor necrosis factor, interleukin‐8, and interleukin‐1β, but not interleukin‐12/natural killer cell stimulating factor mRNAs. Sulfatides also triggered secretion of cytokines into the extracellular medium, although they were much less effective than lypopolysaccharide. Both enhanced expression of cytokine mRNAs and secretion by sulfatides required sulfation of the galactose ring of the glycolipid as non‐sulfated galactocerebrosides had no effect. These findings suggest that sulfatides that are released at sites of inflammation can amplify the inflammatory reaction triggering cytokine expression in, and release by, monocytes.
FEBS Letters | 1992
Maria Cristina Dechecchi; Rossella Rolfini; Anna Tamanini; Chiara Gamberi; Giorgio Berton; Giulio Cabrini
The regulation of chloride conductance was investigated in the T84 human colon carcinoma cell line by the quenching of the fluorescent probe 6‐methoxy‐N‐(3‐sulfopropyl)quinolinium. The permeable cAMP analog 8‐Br‐cAMP (100 μ) and the calcium ionophore ionomycin (1 μM) activate a chloride conductance. A prolonged (4 h) preincubation of cells with phorbol 12‐myristate 13‐acetate (100 nM) or with the diacylglycerol analog 1‐oleoyl‐2‐acetyl‐glycerol (100 μM): (1) down‐modulates to almost zero the protein kinase C activity in the membranes; (ii) inhibits the activation of the chloride conductance mediated by 8‐Br‐cAMP but not by calcium; (iii) reduces the mRNA without changing the expression of the protein product of the cystic fibrosis gene. The data suggest that PKC is essential for the activation of the cAMP‐dependt chloride conductance in T84 cells.
Journal of Innate Immunity | 2015
Sara Nanì; Laura Fumagalli; Uma Sinha; Lynn A. Kamen; Patrizia Scapini; Giorgio Berton
We report that particles of β-glucan, one of the surface components of yeasts, are powerful inducers of neutrophil extracellular trap (NET) formation in human neutrophils. β-Glucan triggered a prolonged phosphorylation of Src family kinases and Syk that were suppressed by the Src family inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3, 4-d] pyrimidine (PP2) and a novel Syk inhibitor, PRT-060318, respectively. PP2 and PRT-060318 also inhibited β-glucan-induced NET formation and reactive oxygen species (ROS) generation, suggesting that both responses are triggered by a Src/Syk-regulated signaling pathway. Given that the NADPH oxidase inhibitor diphenyleneiodonium chloride (DPI) markedly inhibited NET formation, our findings suggest that ROS are required for the full-blown formation of NETs in response to β-glucan particles. Contrary to β-glucan, ROS generation triggered by phorbol myristate acetate (PMA) was unaffected by PP2 and PRT-060318, but these compounds, as well as DPI, suppressed Src/Syk phosphorylation triggered by PMA. Whereas PP2 had no effect on PMA-induced NET formation, PRT-060318 had a significant, albeit partial, inhibitory effect, thus suggesting that ROS induce NET formation in part via activation of Syk. These findings were substantiated by the evidence that neutrophils from mice with the conditional deletion of Syk were defective in formation of NETs in response to β-glucan.
Biochimica et Biophysica Acta | 1985
Giorgio Berton; Emanuele Papini; Marco A. Cassatella; Paolo Bellavite; Filippo Rossi
NADPH oxidase activity was solubilized by detergent treatment of subcellular particles obtained from guinea-pig peritoneal macrophages stimulated with phorbol myristate acetate. Gel filtration of the material containing the NADPH oxidase activity gave two peaks of proteins, one of which eluted with the void and the other with the included volume of an AcA 22 column. The material eluted in the void volume contained more than 50% of the NADPH oxidase activity and less than 10% of the NAD(P)H cytochrome c reductase activity. A b-type cytochrome with peaks of absorption at 558, 528 and 426 nm was also enriched in the fraction which contained the NADPH oxidase activity. The distribution of flavoproteins as revealed by the measurement of FAD was different from that of NADPH oxidase and cytochrome b, and followed the elution profile of NADH cytochrome c reductase. Studies in subcellular particles showed that the b cytochromes of mitochondria and endoplasmic reticulum reduced by selective biochemical means accounted for only a minor part of the total b-type cytochromes and that the new cytochrome b previously described in neutrophils is the major chromophore also in macrophages. Oxidation-reduction midpoint potential of the partially purified cytochrome b was shown to be -247 mV. Association of cytochrome b with the NADPH oxidase activity and its very low Em7.0 makes it a suitable candidate to be part of the superoxide-generating system also in macrophages.
ENZYME | 1991
Anna Tamanini; Giorgio Berton; Giulio Cabrini
The catalytic subunit of cAMP-dependent protein kinase (EC 2.7.1.37) was purified for the first time from human placenta by DEAE-cellulose and HTP chromatography. Sodium dodecyl sulfate/polyacrylamide gel electrophoresis showed a single band of average molecular weight of 42 kDa (SEM = 0.52). Kinetic experiments showed a Km for ATP of 12.6 +/- 1.2 mumol/l, for histone II-AS of 1.3 +/- 0.05 mg.ml-1, for kemptide of 11.4 +/- 4.4 mumol/l. The synthetic inhibitor IP20-amide showed a competitive mechanism of inhibition with a Ki of 5.0 nmol/l. The protein kinase inhibitors H7 and H9 showed an apparent Ki of 8.3 and 4.9 mumol/l respectively. Preparative isoelectric focusing revealed the presence of 5 different isoforms with an average pI of 6.17, 6.70, 7.15, 7.67, 8.9.
Journal of Biological Chemistry | 1994
Carlo Laudanna; Gabriela Constantin; Pierluigi Baron; Elio Scarpini; G. Scarlato; Giulio Cabrini; C Dechecchi; F. Rossi; Marco A. Cassatella; Giorgio Berton
Journal of Cell Biology | 1992
Giorgio Berton; Carlo Laudanna; Claudio Sorio; Filippo Rossi
Journal of Cell Biology | 1994
Giorgio Berton; Laura Fumagalli; Carlo Laudanna; Claudio Sorio